Login
$CERT
$11.39 -$0.18 (1.56%) Live

Company Executives

Officer Age In this role Source
Jon Resnick Also a director
Chief Executive Officer
Not stated Not stated
Faiz Mohammed
Interim CFO
Title from the Form 4 dated Sep 1, 2026
Not stated Not stated
John Reynders Also a director
Chief Financial Officer
Title from the Form 4 dated May 14, 2026
Not stated Not stated
Daniel D. Corcoran
Senior Vice President, General Counsel and Secretary
59 Since 2024
2 years
Rona S. Anhalt
Chief Human Resources Officer
61 Since 2024
2 years
Robert A. Aspbury
PRESIDENT, PREDICTIVE TECH
Title from the Form 4 dated May 11, 2026
54 Not stated
Adrian K. McKemey
President, Certara Drug Development Solutions
61 Since 2025
1 year

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
11
serving now
Independent
10 of 10
stated in the proxy; 1 not stated
Average tenure
0.0 years
from year joined
Director On board Independent 2025 pay Source
Arjun Bedi
2026
this year
Independent Not stated
Stephen McLean
Not stated Independent Not stated
Jon Resnick
Not stated Not stated Not stated
Matthew Walsh
Not stated Independent $246,006
Eran Broshy
Not stated Independent $246,006
Cynthia Collins
Not stated Independent $236,006
John Reynders
Not stated Independent $236,006
Nancy Killefer
Not stated Independent $246,006
James Cashman III
Not stated Independent $313,506
Rosemary Crane
Not stated Independent $233,506
David Spaight
Not stated Independent Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

4 disclosed in the proxy filed Apr 3, 2026
Arsenal
Amount not stated
dated November 3, 2022

Registration Rights Agreement giving Arsenal demand and underwritten offering registration rights for resale of its securities.

With the Company Open in proxy
Arsenal
Amount not stated
through December 8, 2024

Letter Agreement under which Arsenal is prohibited from transferring shares acquired in the EQT/Arsenal transaction until December 8, 2024.

With the Company Open in proxy
Arsenal
Amount not stated
April 14, 2025

Amendment No. 1 to the Letter Agreement extending Arsenal's transfer restriction on acquired shares until April 14, 2026.

With the Company Open in proxy
Arsenal
Amount not stated

Stockholders Agreement giving Arsenal the right to nominate up to two directors to the Board, subject to ownership thresholds.

With the Company Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support